Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI).

When relative change from baseline in the various iron indices were analyzed using the ANCOVA model, with additional adjustments for study treatment and baseline hs-CRP, nominally significant treatment effects were seen for TIBC, transferrin, soluble transferrin receptor, and hepcidin (each P < 0.05; Table 2 ).

also in 5,449 other papers